A SAFETY STUDY OF HUMAN CORD BLOOD DERIVED, CULTURE-EXPANDED, NATURAL KILLER CELL (PNK-007) INFUSION WITH SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-2 (RHIL-2) FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA (MM):